Alverno Labs Launches Ibex AI Platform for Enhanced Cancer Diagnostics
Alverno Labs has implemented Ibex’s AI-powered platform, enhancing cancer diagnosis for prostate, breast, and gastric biopsies.
Read MorePosted by Andy Lundin | Jun 19, 2024 | Cancer |
Alverno Labs has implemented Ibex’s AI-powered platform, enhancing cancer diagnosis for prostate, breast, and gastric biopsies.
Read MorePosted by Chris Wolski | May 24, 2024 | Company News |
Orchard Software has partnered with Pathology & Cytology Laboratories (P&C Labs) in Lexington, Kentucky, to improve the lab’s efficiency.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Prostate |
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.
Read MorePosted by Andy Lundin | Apr 17, 2024 | Cervical (HPV), Sequencing Systems, Urinalysis & Toxicology |
Researchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MorePosted by Chris Wolski | Apr 15, 2024 | Prostate |
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read More